AbClon Competitors and Similar CompaniesClear all
AbClon's competitors and similar companies include Upstream Bio.
 Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 2010 | Founding Date 2021 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations KR HQ | Locations Waltham, US HQ |
Employees | Employees N/A | Employees 38 |
Financial | ||
Revenue (est.) | Revenue (est.) ₩2.3b (FY, 2024) | Revenue (est.) $2.9m (FY, 2025) |
Cost of goods | Cost of goods (₩74.1m) (FY, 2024) | Cost of goods $23m (FY, 2025) |
Gross profit | Gross profit ₩2.4b (FY, 2024) | Gross profit ($20.2m) (FY, 2025) |
Net income | Net income (₩16.3b) (FY, 2024) | Net income ($143.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Upstream Bio
HQ
Waltham, US
Employees
38
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company